13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001600004
Total reported value
$1.6B
$1.6B
37 檔
20.9%
As reported in its official Q1 2025 Form 13F filing, First Light Asset Management, LLC's tracked investment portfolio stood at $1.6B with 37 total positions.
In Q1 2025, First Light Asset Management, LLC displayed an active expansion posture, initiating 37 new positions and adding to 0 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ANAB | Anaptysbio Inc | Stock-Other | 9.84% | -0.42% | +433.28% | |
| 2 | AXGN | Axogen Inc | Stock-Other | 9.45% | -4.16% | -0.72% | |
| 3 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 8.00% | -5.56% | EXIT | |
| 4 | NEO | Neogenomics Inc | Stock-Healthcare | 6.55% | +4.42% | +90.77% | |
| 5 | TWST | Twist Bioscience CORP | Stock-Other | 5.46% | +0.81% | -0.62% | |
| 6 | HCAT | Health Catalyst Inc | Stock-Other | 5.40% | +0.08% | +99.13% | |
| 7 | ATRC | Atricure Inc | Stock-Other | 4.84% | -0.90% | -33.24% | |
| 8 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 4.65% | -0.13% | +137.28% | |
| 9 | PFMTUSD | Performant Financial CORP | Stock-Other | 3.95% | — | +3.05% | |
| 10 | IRTC | Irhythm Holdings Inc | Stock-Healthcare | 3.89% | -0.57% | -24.50% | |
| 11 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 3.28% | -0.45% | -3.39% | |
| 12 | VERA | Vera Therapeutics Inc | Stock-Other | 3.23% | -1.13% | EXIT | |
| 13 | MDXG | Mimedx Group Inc | Stock-Other | 3.00% | -1.01% | EXIT | |
| 14 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 2.61% | — | -17.23% | |
| 15 | SIBN | Si-bone Inc | Stock-Other | 2.58% | +2.00% | +41.81% | |
| 16 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 2.41% | — | -45.90% | |
| 17 | NPCE | Neuropace Inc | Stock-Other | 2.22% | -0.14% | — | |
| 18 | ALHC | Alignment Healthcare Inc | Stock-Other | 2.03% | — | — | |
| 19 | JANX | Janux Therapeutics Inc | Stock-Other | 2.03% | — | +109.96% | |
| 20 | ✓ | Establishment Labs Holdings In | Stock-Other | 1.57% | -0.28% | — | |
| 21 | BFLY | Butterfly Network Inc | Stock-Other | 1.43% | +0.39% | +37.83% | |
| 22 | GH | Guardant Health Inc | Stock-Healthcare | 1.32% | +1.71% | -12.37% | |
| 23 | KRMD | Koru Medical Systems Inc | Stock-Other | 1.29% | -0.60% | -24.69% | |
| 24 | RGEN | Repligen CORP | Stock-Healthcare | 1.28% | — | +6.54% | |
| 25 | ELDN | Eledon Pharmaceuticals Inc | Stock-Other | 0.90% | — | — | |
| 26 | MASS | 908 Devices Inc | Stock-Other | 0.87% | -0.01% | — | |
| 27 | TMDX | Transmedics Group Inc | Stock-Healthcare | 0.83% | — | -22.82% | |
| 28 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 0.78% | — | -4.48% | |
| 29 | FNAUSD | Paragon 28 Inc | Stock-Other | 0.75% | — | -95.27% | |
| 30 | EVH | Evolent Health Inc - A | Stock-Other | 0.63% | — | +991.82% | |
| 31 | INSM | Insmed Inc | Stock-Healthcare | 0.59% | — | -85.51% | |
| 32 | TNDM | Tandem Diabetes Care Inc | Stock-Other | 0.54% | +0.84% | -16.04% | |
| 33 | PODD | Insulet CORP | Stock-Healthcare | 0.51% | — | -49.67% | |
| 34 | PCVX | Vaxcyte Inc | Stock-Other | 0.41% | +0.48% | — | |
| 35 | SENS1GBP | Senseonics Holdings Inc | Stock-Other | 0.35% | — | -27.59% | |
| 36 | LABDGBP | Drx Dly S&p Biotech Bear 3x | ETF-Tech | 0.26% | — | — | |
| 37 | GPCR | Structure Therapeutics Inc | Stock-Other | 0.26% | — | -66.81% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ANAB | Anaptysbio Inc | — | NEW | New buy |
| 2 | AXGN | Axogen Inc | — | NEW | New buy |
| 3 | 260 | Centessa Pharmaceuticals-adr | — | NEW | New buy |
| 4 | NEO | Neogenomics Inc | — | NEW | New buy |
| 5 | TWST | Twist Bioscience CORP | — | NEW | New buy |
| 6 | HCAT | Health Catalyst Inc | — | NEW | New buy |
| 7 | ATRC | Atricure Inc | — | NEW | New buy |
| 8 | EWTX | Edgewise Therapeutics Inc | — | NEW | New buy |
| 9 | PFMTUSD | Performant Financial CORP | — | NEW | New buy |
| 10 | IRTC | Irhythm Holdings Inc | — | NEW | New buy |
| 11 | CRNX | Crinetics Pharmaceuticals In | — | NEW | New buy |
| 12 | VERA | Vera Therapeutics Inc | — | NEW | New buy |
| 13 | MDXG | Mimedx Group Inc | — | NEW | New buy |
| 14 | RARE | Ultragenyx Pharmaceutical In | — | NEW | New buy |
| 15 | SIBN | Si-bone Inc | — | NEW | New buy |
| 16 | XENE | Xenon Pharmaceuticals Inc | — | NEW | New buy |
| 17 | NPCE | Neuropace Inc | — | NEW | New buy |
| 18 | ALHC | Alignment Healthcare Inc | — | NEW | New buy |
| 19 | JANX | Janux Therapeutics Inc | — | NEW | New buy |
| 20 | ✓ | Establishment Labs Holdings In | — | NEW | New buy |
| 21 | BFLY | Butterfly Network Inc | — | NEW | New buy |
| 22 | GH | Guardant Health Inc | — | NEW | New buy |
| 23 | KRMD | Koru Medical Systems Inc | — | NEW | New buy |
| 24 | RGEN | Repligen CORP | — | NEW | New buy |
| 25 | ELDN | Eledon Pharmaceuticals Inc | — | NEW | New buy |
| 26 | MASS | 908 Devices Inc | — | NEW | New buy |
| 27 | TMDX | Transmedics Group Inc | — | NEW | New buy |
| 28 | OSCR | Oscar Health Inc - Class A | — | NEW | New buy |
| 29 | FNAUSD | Paragon 28 Inc | — | NEW | New buy |
| 30 | EVH | Evolent Health Inc - A | — | NEW | New buy |
| 31 | INSM | Insmed Inc | — | NEW | New buy |
| 32 | TNDM | Tandem Diabetes Care Inc | — | NEW | New buy |
| 33 | PODD | Insulet CORP | — | NEW | New buy |
| 34 | PCVX | Vaxcyte Inc | — | NEW | New buy |
| 35 | SENS1GBP | Senseonics Holdings Inc | — | NEW | New buy |
| 36 | LABDGBP | Drx Dly S&p Biotech Bear 3x | — | NEW | New buy |
| 37 | GPCR | Structure Therapeutics Inc | — | NEW | New buy |
According to official SEC Form 13F filings, First Light Asset Management, LLC reported a total U.S. public equity portfolio value of $1.6B across 37 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ANAB, AXGN, 260) accounted for 20.9% of total reported equity market value during Q1 2025.
Top New Position Initiated
ANAB
市值: $86.1M
During Q1 2025, First Light Asset Management, LLC's top holdings by market value included ANAB (9.8%)、AXGN (9.4%)、260 (8.0%). The largest single position, ANAB, represented 9.8% of total portfolio value.
In Q1 2025, First Light Asset Management, LLC made 37 total portfolio adjustments, initiating 37 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.